Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May 1;2014(5):1901-1907.

Metal-catalyzed uncaging of DNA-binding agents in living cells

Affiliations

Metal-catalyzed uncaging of DNA-binding agents in living cells

Mateo I Sánchez et al. Chem Sci. .

Abstract

Attachment of alloc protecting groups to the amidine units of fluorogenic DNA-binding bisbenzamidines or to the amino groups of ethidium bromide leads to a significant reduction of their DNA affinity. More importantly, the active DNA-binding species can be readily regenerated by treatment with ruthenium catalysts in aqueous conditions, even in cell cultures. The catalytic chemical uncaging can be easily monitored by fluorescence microscopy, because the protected products display both different emission properties and cell distribution to the parent compounds.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Structure of selected DNA binders: pentamidine (1), propamidine (2), phenyl azapentamidine (3), DAPI (4) ethidium bromide (5).
Fig. 2
Fig. 2
Top: Structures of the alloc (©3), and allyl (6) protected derivatives of bisbenzamidine 3. Bottom: fluorescence emission of 5 μM solutions of 3 and ©3 in Tris-HCl 20 mM, 100 mM NaCl, pH 7.5 (dashed lines), and in the presence of 1 equiv. of h-A3·T3 (solid lines). h-A3·T3: 5′-GGC-AAATTT-CAGTTTTTCTG-AAATTT-GCC-3′.
Fig. 3
Fig. 3
Top: catalytic deprotection in phosphate buffer and 10% DMSO. Bottom: HPLC trace of the uncaging reaction in phosphate buffer 100 mM pH 7.5, and 10% DMSO. (a) ©3 (75 mM); (b) ©3 + PhSH (325 mM); (c) ©3 + PhSH + [Ru] (10%), t = 1 min; (d) ©3 + PhSH + [Ru], t = 20 min.
Fig. 4
Fig. 4
Top: Structure of ©4. Bottom: fluorescence spectra of DAPI (4) and ©4 in the absence (dashed lines) and in the presence of 1 equiv. of h-A2·T2 (solid lines). Experiments were carried out using 0.2 μM of ©4 and 4 in TrisHCl 20 mM, 100 μM NaCl, pH 7.5 at 20 °C. Sequence of: h-A2·T2: 5′-GGCG AATT CAGCTTTTTGCTG AATT GCC-3′.
Fig. 5
Fig. 5
Top: Structure of ©5. Bottom: fluorescence emission spectra of 1 μM 5 and ©5 (dashed lines), and spectra of both compounds in the presence of 0.3 mg mL −1 of ct-DNA (solid lines). Spectra of 5 and of 5 in the presence of ct-DNA are represented multiplied by a factor of 10 for comparison. λexc 5 = 545 nm, λexc ©5 = 300 nm.
Fig. 6
Fig. 6
HPLC trace of the deprotection reaction of ©5. (a) ©5 in buffer (50 mM); (b) ©5 + PhSH (250 mM) + ct-DNA (0.1 mg ml −1); (c) ©5 + PhSH + ct-DNA + Ru (10%) t = 0; (d) ©5 + PhSH + ct-DNA + Ru t 20 min; (e) ©5 + PhSH + ct-DNA + Ru t = 1 h. Inset: picture (left to = right) of the aliquots a, b, c and e.
Fig. 7
Fig. 7
Ru-catalyzed deprotection of 2.5 μM ©4 in CEF cells: (a) ©4, 30 min at 37 °C, blue channel; (b) ©4, 30 min at 37 °C, brightfield; (c) ©4 treated with 2.5 μM [Ru] and 100 μM PhSH, 8 min, blue channel; (d) ©4 treated with 2.5 μM [Ru] and 100 μM PhSH, 8 min, brightfield; (e) ©4 treated 20 min with 2.5 μM [Ru] and 100 μM PhSH, 20 min, blue channel; (f) ©4 treated 20 min with 2.5 μM [Ru] and 100 μM PhSH, 20 min, brightfield. (g) control with 2.5 μM 4 after 30 min at 37 °C, blue channel; (h) control with 15 μM 4 after 30 min, 37 °C, blue channel. Blue channel fluorescence microscopy settings: excitation filter 360–370 nm, emission filter 420 nm and dichromatic mirror 400 nm.
Fig. 8
Fig. 8
Ru-catalyzed deprotection of 2.5 μM of ©4 in Vero cells. Top row: ©4, 30 min at 37 °C (a) blue channel; (b) brightfield. Bottom row: ©4 with 2.5 μM [Ru] and 100 μM PhSH, 20 min; (c) blue channel; (d) brightfield.
Fig. 9
Fig. 9
Ru-catalyzed deprotection of 10 μM ©5 in CEF cells. Left column: ©5, 30 min at 37 °C; (a) green channel; (b) brightfield; (c) red channel. Right column: ©5 incubated with 20 μM [Ru] and 100 μM PhSH, 20 min; (d) green channel; (e) brightfield; (f) red channel. Fluorescence microscopy settings for green channel: filter 530–550 nm, emission filter 590 nm and dichromatic mirror 570 nm; and for red channel: filter 530–550 nm, emission filter 590 nm and dichromatic mirror 570 nm.

References

    1. Vázquez ME, Caamaño AM, Mascareñas JL. Chem. Soc. Rev. 2003;32:338. - PubMed
    2. Pazos E, Mosquera J, Vázquez ME, Mascareñas JL. ChemBioChem. 2011;12:1958. - PubMed
    3. Chaires JB. Curr. Opin. Struct. Biol. 1998;8:314–320. - PubMed
    1. Dervan PB, Bürli RW. Curr. Opin. Chem. Biol. 1999;3:688–693. - PubMed
    2. Reddy BS, Sondhi SM, Lown JW. Pharmacol. Ther. 1999;84:1–111. - PubMed
    3. Sato S-I, Hagihara M, Sugimoto K, Morii T. Chem.–Eur. J. 2002;8:5066–5071. - PubMed
    4. Vázquez ME, Caamaño AM, Martínez-Costas J, Castedo L, Mascareñas JL. Angew. Chem., Int. Ed. 2001;40:4723. - PubMed
    5. Vazquez O, Vázquez ME, Blanco JB, Castedo L, Mascarenas JL. Angew. Chem., Int. Ed. 2007;46:6886–6890. - PubMed
    6. Bordello J, Sánchez MI, Vázquez ME, Mascareñas JL, Al-Soufi W, Novo M. Angew. Chem., Int. Ed. 2012;51:7541–7544. - PubMed
    1. Morgan S-A, Woolley GA. Photochem. Photobiol. Sci. 2010;9:1320–1326. - PubMed
    2. Andersson J, Li S, Lincoln P, Andréasson J. J. Am. Chem. Soc. 2008;130:11836–11837. - PubMed
    3. Park S, Bando T, Shinohara K-I, Nishijima S, Sugiyama H. Bioconjugate Chem. 2011;22:120–124. - PubMed
    4. Nomura A, Okamoto A. Chem. Commun. 2009:1906–1908. - PubMed
    5. Di Pietro ML, Puntoriero F, Tuyéras F, Ochsenbein P, Lainé PP, Campagna S. Chem. Commun. 2010;46:5169–5171. - PubMed
    6. Caamaño AM, Vazquez ME, Martinez-Costas J, Castedo L, Mascareñas JL. Angew. Chem., Int. Ed. 2000;39:3104–3107. - PubMed
    7. Jiménez A, Pazos E, Martínez-Albardonedo B, Mascareñas JL, Vazquez ME. Angew. Chem., Int. Ed. 2012;51:8825–8829. - PubMed
    8. Mosquera J, Jiménez A, Dodero VI, Vázquez ME, Mascareñas JL. Nat. Commun. 2013;4:1874–1878. - PubMed
    1. Sánchez MI, Vazquez O, Vazquez ME, Mascareñas JL. Chem. Commun. 2011;47:11107–11109. - PubMed
    2. Sánchez MI, Martinez-Costas J, Gonzalez F, Bermudez MA, Vazquez ME, Mascareñas JL. ACS Chem. Biol. 2012;7:1276–1280. - PubMed
    1. Rautio J, Kumpulainen H, Heimbach T, Oliyai R, Oh D, Järvinen T, Savolainen J. Nat. Rev. Drug Discovery. 2008;7:255–270. - PubMed

LinkOut - more resources